Impact of chronic kidney disease on postinfarction inflammation, oxidative stress, and left ventricular remodeling

Kotaro Naito1, Toshihisa Anzai, Tsutomu Yoshikawa

  • 1Division of Cardiology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Insights

Chronic kidney disease (CKD) worsens outcomes after myocardial infarction (MI). CKD patients experienced more cardiac events and adverse left ventricular (LV) remodeling, linked to increased inflammation and oxidative stress.

Area of Science:

  • Cardiology
  • Nephrology
  • Biomarkers

Background:

  • Chronic kidney disease (CKD) is associated with poor clinical outcomes in patients following myocardial infarction (MI).
  • The underlying mechanisms linking CKD and adverse post-MI outcomes, particularly concerning left ventricular (LV) remodeling, remain incompletely understood.

Purpose of the Study:

  • To investigate the prognostic significance of CKD in patients with MI.
  • To determine the relationship between CKD and LV remodeling after MI.

Main Methods:

  • Study included 120 patients with a first anterior ST-elevation MI who underwent reperfusion therapy.
  • Patients were stratified into two groups based on the presence (estimated glomerular filtration rate <60 mL/min/1.73 m²) or absence of CKD.
  • Clinical outcomes, LV remodeling parameters (volume and ejection fraction), and inflammatory/oxidative stress markers were assessed.

Main Results:

  • CKD patients exhibited higher in-hospital cardiac death and heart failure readmission rates.
  • CKD was associated with greater LV volume and reduced LV ejection fraction at 2 weeks post-MI.
  • CKD independently predicted major adverse cardiac events (hazard ratio=3.13, P=.001).
  • Elevated levels of interleukin-6, C-reactive protein, and malondialdehyde-modified low-density lipoprotein were observed in CKD patients.

Conclusions:

  • CKD patients face poorer clinical outcomes post-MI compared to non-CKD patients.
  • CKD accelerates infarct expansion and LV remodeling, associated with heightened inflammation and oxidative stress.
  • CKD significantly impacts the development of LV remodeling after myocardial infarction.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...